250 related articles for article (PubMed ID: 31686633)
1. Novelty in Inflammation and Immunomodulation in Migraine.
Cavestro C; Ferrero M; Mandrino S; Di Tavi M; Rota E
Curr Pharm Des; 2019; 25(27):2919-2936. PubMed ID: 31686633
[TBL] [Abstract][Full Text] [Related]
2. Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
Pellesi L; Do TP; Ashina H; Ashina M; Burstein R
Headache; 2020 Jun; 60(6):1056-1065. PubMed ID: 32437038
[TBL] [Abstract][Full Text] [Related]
3. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
Lukacs M; Tajti J; Fulop F; Toldi J; Edvinsson L; Vecsei L
Curr Med Chem; 2017; 24(33):3649-3665. PubMed ID: 28707585
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment.
Dominguez-Moreno R; Do TP; Ashina M
Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):225-231. PubMed ID: 35066541
[TBL] [Abstract][Full Text] [Related]
6. CGRP and migraine: could PACAP play a role too?
Kaiser EA; Russo AF
Neuropeptides; 2013 Dec; 47(6):451-61. PubMed ID: 24210136
[TBL] [Abstract][Full Text] [Related]
7. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
Melo-Carrillo A; Strassman AM; Nir RR; Schain AJ; Noseda R; Stratton J; Burstein R
J Neurosci; 2017 Nov; 37(44):10587-10596. PubMed ID: 28972120
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide and migraine.
Karsan N; Goadsby PJ
Curr Opin Neurol; 2015 Jun; 28(3):250-4. PubMed ID: 25887765
[TBL] [Abstract][Full Text] [Related]
9. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
10. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
11. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum neurotoxin--a therapy in migraine].
Tajti J; Szok D; Tuka B; Csáti A; Kuris A; Majláth Z; Lukács M; Vécsei L
Ideggyogy Sz; 2012 Mar; 65(3-4):77-82. PubMed ID: 23136725
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
14. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
Melo-Carrillo A; Noseda R; Nir RR; Schain AJ; Stratton J; Strassman AM; Burstein R
J Neurosci; 2017 Jul; 37(30):7149-7163. PubMed ID: 28642283
[TBL] [Abstract][Full Text] [Related]
15. Biochemical Modulation and Pathophysiology of Migraine.
Chan C; Wei DY; Goadsby PJ
J Neuroophthalmol; 2019 Dec; 39(4):470-479. PubMed ID: 31714319
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
Pellesi L; Guerzoni S; Pini LA
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
[TBL] [Abstract][Full Text] [Related]
17. [Basic mechanisms of migraine and new methods of treatment].
Hansen JM; Ashina M
Ugeskr Laeger; 2016 Dec; 178(51):. PubMed ID: 28041540
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.
Ong JJY; Wei DY; Goadsby PJ
Drugs; 2018 Mar; 78(4):411-437. PubMed ID: 29396834
[TBL] [Abstract][Full Text] [Related]
19. CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
Yuan H; Lauritsen CG; Kaiser EA; Silberstein SD
BioDrugs; 2017 Dec; 31(6):487-501. PubMed ID: 29116598
[TBL] [Abstract][Full Text] [Related]
20. Fremanezumab for the preventive treatment of migraine in adults.
Lionetto L; Curto M; Cisale GY; Capi M; Cipolla F; Guglielmetti M; Martelletti P
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):741-748. PubMed ID: 31220963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
